Press Releases - Cardiol Therapeutics

Investor Resources

Contact Us

Investor ResourcesPress Releases

Press Releases

Cardiol Therapeutics Appoints Michael J. Willner, Esq. as Business Advisor

December 18, 2019

Cardiol Therapeutics Appoints Former GW Pharmaceuticals Executive Colin Stott to its Board of Directors

December 3, 2019

Cardiol Therapeutics comments on the Descheduling of Purisys Cannabinoid Ingredients by U.S. Drug Enforcement Agency

November 25, 2019

Cardiol Therapeutics Announces Clinical Steering Committee for Phase 2 International Trial in Acute Myocarditis Using CardiolRx™100

November 19, 2019

Cardiol Therapeutics Announces Completion of Manufacturing Scale-up for Commercialization of CardiolRx™100

October 1, 2019

Cardiol Therapeutics to Webcast Live at VirtualInvestorConferences.com on September 12^th

September 5, 2019

Cardiol Therapeutics to Present at Canaccord Genuity 39th Annual Growth Conference

July 29, 2019

Cardiol Therapeutics Announces Plans for Orphan Drug Program in Acute Myocarditis with CardiolRx CBD Formulation

June 20, 2019

Cardiol Therapeutics Reports 2018 AGM Results

June 13, 2019